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Abstract 34 
An important feature of Mycobacterium tuberculosis pathogenesis is the ability to control 35 
cell death in infected host cells, including inhibition of apoptosis and stimulation of necrosis.  36 
Recently an alternative form of programmed cell death, necroptosis, has been described 37 
where necrotic cell death is induced by apoptotic stimuli under conditions where apoptotic 38 
execution is inhibited.  We show for the first time that M. tuberculosis and TNFα synergise 39 
to induce necroptosis in murine fibroblasts via RIPK1-dependent mechanisms and 40 
characterized by phosphorylation of Ser345 of the MLKL necroptosis death effector.  41 
However, in murine macrophages M. tuberculosis and TNFα induce non-necroptotic cell 42 
death that is RIPK1-dependent but independent of MLKL phosphorylation. Instead, M. 43 
tuberculosis-infected macrophages undergo RIPK3-dependent cell death which occurs both 44 
in the presence and absence of TNFα and involves the production of mitochondrial ROS.  45 
Immunocytochemical staining for MLKL phosphorylation further demonstrated the 46 
occurrence of necroptosis in vivo in murine M. tuberculosis granulomas. Phosphorylated-47 
MLKL immunoreactivity was observed associated with the cytoplasm and nucleus of 48 
fusiform cells in M. tuberculosis lesions but not in proximal macrophages.  Thus whereas 49 
pMLKL-driven necroptosis does not appear to be a feature of M. tuberculosis-infected 50 
macrophage cell death, it may contribute to TNFα-induced cytotoxicity of the lung stroma 51 
and therefore contribute to necrotic cavitation and bacterial dissemination.   52 
 53 
  54 
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Introduction 55 
Mycobacterium tuberculosis is an intracellular pathogen that resides predominantly in 56 
macrophages but also in other cells including dendritic cells and non-professional 57 
phagocytes such as fibroblasts, adipocytes and endothelial cells 1, 2 3. The bacterium has 58 
evolved sophisticated and robust systems to control the biology of its host cell; preserving 59 
its replicative niche, avoiding innate antimicrobial mechanisms and manipulating the 60 
generation of adaptive immunity 4, 5. The fine control of inflammation is particularly 61 
important for M. tuberculosis because the bacterium must avoid stimulation of immunity 62 
that will limit its infection whilst maintaining the immune driven generation of a necrotic 63 
pulmonary granuloma, cavitation and subsequent respiratory transmission. 64 
 65 
An important component of M. tuberculosis pathogenesis is the complex control over the 66 
mode and timing of host cell death.   In general terms, macrophages infected with M. 67 
tuberculosis may undergo cell death by two mechanisms, apoptosis or necrosis, with 68 
drastically different outcomes for the host and bacterium.  Several studies have 69 
demonstrated that apoptosis of infected macrophages results in killing of mycobacteria 6-10, 70 
probably by efferocytosis of mycobacteria-containing apoptotic bodies and subsequent 71 
lysosomal digestion or oxidative killing 11, 12. Additionally, macrophage apoptosis stimulates 72 
protective T cell responses through the “detour” pathway of antigen presentation 13-15.  In 73 
contrast, necrosis has been observed to facilitate release of viable bacteria from infected 74 
macrophages 8, 16 which may be taken up by phagocytes attracted by damage associated 75 
molecular patterns (DAMPs) released by the necrotic macrophage 17, 18. This would allow 76 
further intracellular replication producing a cycle of host cell infection, necrosis and 77 
reinfection that may represent an important part of the generation of necrotic granuloma.  78 
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Indeed, stimulation of necrosis is a hallmark of virulent mycobacterial strains 16 19, 20 and as 79 
such stimulation of necrosis is considered a virulence mechanism of M. tuberculosis.   80 
 81 
In more specific terms, it has become apparent that M. tuberculosis is able to exert an 82 
exquisitely complex control over cell death of the host cell, by having the capacity to both 83 
induce and inhibit apoptosis and induce necrosis of the host cell.  Apoptosis can be induced 84 
by the extrinsic (death receptor) or intrinsic (mitochondrial) pathways.  M. tuberculosis is 85 
able to inhibit tumour necrosis factor alpha (TNFα)-mediated extrinsic apoptosis via a 86 
number of mechanisms including secretion of soluble TNF receptor 2 (sTNFR2) 21, 87 
downregulation of  pro-caspase-8 transcription 22, suppression of caspase-8 expression 23, 88 
and upregulation of caspase-8-inhibiting FLIP molecules transcription 22.  However, 89 
inhibition of the extrinsic pathway occurs in the context of activation of the intrinsic 90 
mitochondrial pathway 23.   During infection with avirulent mycobacterial strains such as 91 
H37Ra, mitochondrial outer membrane permeablisation and release of cytochrome C lead 92 
to host cell apoptosis 23.  However virulent mycobacterial strains such as H37Rv induce 93 
irreversible mitochondrial inner membrane permeablisation, leading to mitochondrial 94 
permeability transition (MPT), causing further loss of mitochondrial integrity and function 23.   95 
This, plus further mechanisms inhibiting plasma membrane repair 24, leads to necrosis of the 96 
macrophage.  Thus a model of macrophage infection has emerged where mycobacteria 97 
preserve themselves and their macrophage hosts by inhibition of apoptosis and then exit 98 
the cell to disseminate further via necrosis.  99 
 100 
Necrosis of cells can be induced by a variety of cellular stresses and until recently was 101 
considered to be a disordered mode of death that did not involve intracellular signalling 102 
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pathways.  However, in the last decade, highly coordinated modes of programmed necrotic 103 
cell death have been described.   Necroptosis is a pharmacologically tractable necrosis 25, 104 
that can be induced by death receptors including TNFR1 26, 27, type I interferon 28, and 105 
recognition of pathogen-associated molecular patterns (PAMPS) by pattern recognition 106 
receptors including toll-like receptors TLR3, TLR4, and the cytosolic DNA-dependent 107 
activator or IFN regulatory factors DAI/ZBP1   29. Necroptosis occurs when cell death is 108 
induced by apoptotic stimuli under conditions where apoptotic execution is inhibited.  In the 109 
case of TNFα stimulated necroptosis, when TNFα signalling occurs in the presence of 110 
caspase inhibition (such as the pan caspase inhibitor zVAD.fmk 30), the receptor interacting 111 
kinases RIPK1 and RIPK3 associate and become phosphorylated and the pseudokinase mixed 112 
lineage kinase domain-like protein (MLKL) is recruited and phosphorylated by pRIPK3 27, 31, 113 
32.  The resulting complex translocates to the nucleus and then to the cell membrane where 114 
oligomerized pMLKL has pore forming activity and causes necrotic cell lysis 33.  Necroptosis 115 
can be inhibited using the RIPK1 inhibitor necrostatin-1 (Nec-1) 34, 35.   RIPK1 also plays a role 116 
in cell survival by limiting capsase-8 and TNFR-induced apoptosis 36, as demonstrated by 117 
perinatal lethality in ripk1-/- mice 37.  Additionally, RIPK1 in complex with RIPK3, FADD and 118 
caspase-8 can mediate apoptosis; as such RIPK1 dependence of cell death (such as cell 119 
death that can be inhibited by Nec-1) does not in itself confirm necroptosis as a mechanism 120 
25.   121 
 122 
Necroptosis has been described in a number of pathological conditions with overt 123 
inflammatory signatures including Crohn’s disease 38, and acts as a defence mechanism 124 
against some viral pathogens such as Vaccinia virus and murine cytomegalovirus 26, 39, 40. 125 
Accordingly, viruses have evolved mechanisms to inhibit necroptosis to counter this 126 
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mechanism 40, 41. Necroptosis has also been observed in bacterial infections including 127 
Salmonella and Listeria, where its induction was associated with loss of immune control and 128 
increased pathogen replication 28, 42.  More recently, programmed necrosis was reported in 129 
Mycobacterium marinum infection of leukotriene A4 hydrolase (LTA4H) mutant zebrafish, 130 
which express high levels of TNFα 43.  131 
 132 
TNFα is a pivotal cytokine in tuberculosis, being essential for protection but, paradoxically, 133 
at high levels also responsible for the generation of tissue necrosis, increased tissue 134 
pathology and enhanced bacterial growth 43-46.  Given that M. tuberculosis is able to inhibit 135 
extrinsic apoptosis pathways in the context of high circulating levels of TNFα, our focus was 136 
drawn to the potential role of TNFα stimulated necroptosis in M. tuberculosis infection.    137 
 138 
Much of what we know about M. tuberculosis host cell death has been gained from studies 139 
of macrophage infection. However, it has long been established that infection with M. 140 
tuberculosis sensitises fibroblasts to TNFα toxicity 47, 48.   Of further intrigue, infected 141 
fibroblasts are seen in the lungs of cadavers with latent M. tuberculosis infection but are not 142 
seen during active M. tuberculosis infection 2.  An enhanced sensitivity of infected 143 
fibroblasts to TNFα has been postulated to account for this but no mechanistic detail of the 144 
mode of cell death has been elucidated 48.   145 
 146 
Given the prominent role of TNFα in tuberculosis and the capacity of M. tuberculosis to 147 
inhibit apoptosis in macrophages and sensitize fibroblasts the toxic effects of TNFα, we 148 
hypothesised that necroptosis may occur during M. tuberculosis infection and may 149 
represent an important mode of necrotic cell death. Thus, we investigated the occurrence of 150 
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necroptosis in infected murine macrophage and fibroblast cells in the presence of TNFα.  To 151 
definitively demonstrate the presence or absence of necroptosis, we determined the 152 
occurrence of phosphorylated MLKL in cells exposed to TNFα, and in vivo in murine 153 
granulomatous M. tuberculosis lesions.   154 
155 
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Results 156 
In order to investigate the presence of necroptosis in response to M. tuberculosis infection, 157 
we first compared the capability of murine fibroblasts and human and murine macrophages 158 
to undergo necroptosis induced by TNFα + zVAD treatment, as this capacity is not universal 159 
in eukaryotic cells 27.  Monolayers of cells (plus control wells) were treated with TNFα (plus 160 
DMSO control), TNFα+zVAD, or TNFα+zVAD+Nec-1.  After 20 hours, cell survival was 161 
determined by crystal violet assay.  As seen in figure 1a-b, primary human monocyte-162 
derived macrophages and U937 macrophages underwent cell death in response to 163 
TNFα+zVAD treatment, and this could be inhibited by the RIPK1 inhibitor Nec-1.  However, 164 
THP-1 macrophages (figure 1c) were not sensitive to TNFα+zVAD treatment.  In the murine 165 
system, L929 fibroblasts (a cell type well characterised in its ability to undergo necroptosis 166 
27, and J774A.1 macrophages underwent cell death in response to TNFα+zVAD treatment, 167 
and cell death could be inhibited by Nec-1 (figure 1d-e).  However, RAW 264.7 macrophages 168 
did not share the capacity to undergo cell death stimulated by TNFα+zVAD treatment (figure 169 
1f).   170 
 171 
We focussed on characterising cell death in murine L929 fibroblasts and murine J774A.1 172 
macrophages.  As seen in figure 1g, cell death induced by TNFα+zVAD treatment in both 173 
L929 fibroblasts and J774A.1 macrophages was confirmed to be necroptosis by detection by 174 
Western blot of phosphorylation of MLKL at Ser345, which represents an essential step in 175 
the canonical effector mechanism of necroptotic death 49.  We further sought to 176 
characterise the cell death characteristics of J774A.1 macrophages undergoing necroptosis.  177 
J774A.1 cells were induced to undergo apoptosis (by treatment with cyclohexamide), 178 
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necrosis (by H2O2-treatment) and necroptosis (by TNFα+zVAD treatment) and examined by 179 
confocal microscopy.  As seen in figure 1h, cells undergoing necroptosis undergo necrotic 180 
cell death that lacks the apoptotic hallmarks of nuclear condensation and fragmentation 181 
that are hallmarks of apoptosis.   182 
 183 
Having demonstrated that L929 fibroblasts and J774A.1 macrophages are able to undergo 184 
necroptosis, we next investigated the presence of necroptosis in M. tuberculosis infection of 185 
these cell types.   L929 fibroblasts and J774A.1 macrophages were infected with M. 186 
tuberculosis in the presence and absence of TNFα and the RIPK1 inhibitor Nec-1.  Cell 187 
survival was determined using a crystal violet assay.  As seen in figure 2a and figure 2c, M. 188 
tuberculosis induced cell death in both L929 fibroblasts and J774A.1 macrophages in a dose-189 
dependent manner.  In the absence of TNFα this cell death was not inhibited by Nec-1 and 190 
thus was not dependent on RIPK1.  Addition of TNFα to the cultures following infection 191 
induced an additional proportion of cell death that was inhibited by Nec-1, demonstrating 192 
RIPK1-dependent cell death in both cell lines in the combined presence of TNFα and M. 193 
tuberculosis infection.  We next investigated the ability of M. tuberculosis and TNFα to 194 
induce phosphorylation of MLKL at Ser345 (pMLKL).   The Western blot in figure 2b shows 195 
M. tuberculosis and TNFα synergise to induce necroptosis via phosphorylation of Ser345 of 196 
MLKL in L929 fibroblast cells.  However, despite the capability of J774A.1 to undergo 197 
necroptosis, and the occurrence of RIPK1-dependent cell death in M. tuberculosis and TNFα 198 
treated macrophages, these dying cells did not undergo phosphorylation of MLKL (figure 199 
2d).  Thus, we conclude that M. tuberculosis does not induce classical necroptosis in this 200 
macrophage cell type.   201 
 202 
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We further sought to characterise the involvement of other effector molecules of the 203 
necroptotic pathway in macrophage cell death in response to M. tuberculosis infection in 204 
the presence and absence of TNFα.  In the M. marinum/zebrafish model of tuberculosis, 205 
TNFα excess leads to RIPK1-RIPK3 dependent cell death mediated through 206 
phosphoglycerate mutase family member 5 PGAM5 and mitochondrial reactive oxygen 207 
species (ROS) production 43.  We therefore investigated the role of RIPK3 in J774A.1 208 
macrophages by silencing the RIPK3 gene using sh-RNA (figure 3a-b).  As seen in figure 3c, 209 
RIPK3-deficient macrophages were protected from cell death induced by M. tuberculosis, 210 
however this effect was independent of TNFα signalling.  Furthermore, addition of the 211 
mitochondrial ROS inhibitor Necrox-2 (figure 3d) was similarly able to rescue a proportion of 212 
cell death in M. tuberculosis infected macrophages, and this effect was similarly 213 
independent of TNFα signalling.  Thus although pMLKL-driven necroptosis through TNFα-214 
signalling does not occur in murine macrophages, pharmacologically tractable programmed 215 
necrosis driven by RIPK3 and mitochondrial ROS does occur in this cell type in response to 216 
M. tuberculosis infection.   217 
 218 
We finally sought to investigate the presence of pMLKL-driven necroptosis in vivo in mice 219 
infected with M. tuberculosis.  Granulomatous TB lesions were immunostained for pMLKL.  220 
As seen in figure 4a, granulomatous regions were heavily consolidated with abundant acid 221 
fast bacilli (figure 4a inset), morphologically identifiable foamy macrophages and areas of 222 
necrosis.  pMLKL immunohistochemistry of the M. tuberculosis infected lungs demonstrated 223 
necroptosis specifically in cells in granulomatous regions with necrotic debris (figure 4c-d).  224 
Both nuclear and cytoplasmic staining was observed in these cells, consistent with the 225 
scenario that upon activation, pMLKL translocates first to the nucleus and then to the 226 
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cytoplasm 33.  It is not possible in our study to definitively determine the identity of pMLKL-227 
positive cells but it was notable that obvious foamy macrophages were pMLKL negative 228 
even in areas where proximal cells were pMLKL-positive (figure 4d, white arrow).  229 
Additionally, pMLKL-positivity tended to occur in cells with a fusiform nuclear and cell body 230 
morphology which is consistent with non-professional phagocytes such as fibroblasts of the 231 
lung stroma 2.   232 
 233 
 234 
 235 
 236 
 237 
 238 
 239 
 240 
 241 
 242 
 243 
 244 
 245 
 246 
 247 
 248 
 249 
 250 
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 251 
 252 
Discussion 253 
There is compelling evidence that M. tuberculosis exerts a finely balanced control over the 254 
mode of death of its parasitized host cell 19, 50.  A number of studies show that following a 255 
period of apoptosis inhibition, infected macrophages undergo a form of death that 256 
resembles necrosis. This is supported by the experimental observations that low 257 
multiplicities of infection with virulent M. tuberculosis inhibit macrophage apoptosis51, 258 
whereas high multiplicities of infection result in necrosis 19, 52, 53.  The association of this 259 
phenomenon with virulent mycobacterial strains 19, 20, 23, 54, 55 has led to a postulated 260 
scenario that necrosis is a virulence mechanism which enables bacterial escape to infect 261 
new phagocytes or into the extracellular milieu, concurrent with the generation of 262 
inflammation to drive the development of a necrotic granuloma which is essential for 263 
transmission.  As is the case for many virulence features of M. tuberculosis, there appears to 264 
be a plethora of mechanisms that contribute to the regulation/inhibition of apoptosis. These 265 
may include ligation of TLR2 receptors by bacterial ligands such as lipoarabinomannan 266 
(LAM) and the 19KDa lipoprotein 56, 57, the activities of bacterial nuoG 58 and SecA2 59, and 267 
upregulation of host anti-apoptotic proteins Mcl-1 60 and the Bcl-2 family member bfl-1/A1 268 
61. However, there is a paucity of information regarding the mechanisms by which M. 269 
tuberculosis infected cells undergo necrosis, although individual molecular players are being 270 
discovered such as Rv2626c and PPE68; these genes contribute to induction of 271 
mitochondria-driven necrosis and enhance bacterial escape from the macrophage 62 .    272 
 273 
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There are likely a number of ways that M. tuberculosis causes cellular necrosis, but here we 274 
demonstrate for the first time that in a microenvironment of excess TNFα, M. tuberculosis-275 
infected murine fibroblasts undergo necroptosis via RIP1K- and pMLKL-dependent 276 
mechanisms.  Murine macrophages undergo RIPK1-dependent necrosis-like cell death, but 277 
do not undergo necroptosis because the scenario was not associated with phosphorylation 278 
of the MLKL death effector.  We additionally demonstrate that necroptosis occurs in vivo in 279 
murine lung granulomas, where foamy macrophages lack pMLKL yet were spatially close to 280 
pMLKL-expressing cells including those with fusiform nuclei resembling fibroblasts 2.   281 
 282 
Necroptosis has been implicated as a mechanism of cell death in response to a range of 283 
micro-organisms including murine cytomegalovirus, Vaccinia virus, Salmonella typhimurium, 284 
and Mycobacterium marinum 43, 63.  However, direct comparison between these studies is 285 
complicated by varying definitions of “necroptosis”, as not all studies demonstrate definitive 286 
phosphorylation of MLKL.  In the M. marinum/zebrafish model of tuberculosis, TNFα excess 287 
leads to RIPK1-RIPK3 dependent cell death, involving PGAM5 and mitochondrial ROS 288 
production 43.  Although use of the MLKL inhibitor necrosulfonamide suggested a role for 289 
MLKL in programmed cell death in this scenario, definitive phosphorylation of MLKL was not 290 
demonstrated.  Furthermore, recent phylogenetic analysis has shown that the members of 291 
the necroptotic signalling pathway are not well conserved through the animal kingdom; 292 
notably, MLKL is not present in zebrafish, suggesting that the M. marinum/zebrafish model 293 
does not fully replicate the programmed necrosis pathways of M. tuberculosis/macrophage 294 
infections when investigating pMLKL-driven necroptosis 64.  Of further importance, not all 295 
cell lines are susceptible to necroptosis induced by TNFα and zVAD, which has been shown 296 
in some cell types to correlate with RIPK3 expression 27.  In our hands, human primary 297 
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macrophages, human U937 cells, murine J774A.1 cells and murine L929 cells were sensitive 298 
to TNFα+zVAD treatment, whereas THP-1 macrophages and RAW macrophages were not.  299 
Furthermore, the ability of J774A.1 macrophages and L929 fibroblasts to undergo pMLKL- 300 
dependent necroptosis was confirmed by Western blot, demonstrating their suitability for 301 
studying necroptosis.    As necrotic pathways were the focus of this study, high MOIs (10-40) 302 
were used to infect macrophages and fibroblasts; cell death was observed to occur in a 303 
dose-dependent manner.  Infection of macrophages with low MOI (MOI 3) was not able to 304 
stimulate RIPK1-dependent cell death in the presence of TNFα.  It would be interesting to 305 
determine whether necroptosis occurs at low multiplicities of infection (when inhibition of 306 
apoptosis occurs) or whether it is a necrotic death phenotype that is exclusively dependent 307 
on a high multiplicity of infection.   308 
 309 
During the preparation of this manuscript, Zhao et. al. published an elegant study 310 
demonstrating a key role of RIPK3 in inducing necrosis in M. tuberculosis-infected 311 
macrophages  65.  They demonstrate that during infection of macrophages with virulent M. 312 
tuberculosis, a complex of RIPK1/RIPK3/pro-caspase-8 translocates to the mitochondria.  313 
Due to the presence of RIPK3 and Bcl-xL at the mitochondrial membrane, pro-caspase-8 314 
remains in its inactive zymogen form; BAK/BAX activation is not initiated and this results in 315 
an inhibition of intrinsic apoptosis.  However, RIPK3 is able to stimulate ROS-dependent 316 
necrosis by enhancing the binding of hexokinase II to the voltage dependent anion channel 317 
(VDAC) on the mitochondrial membrane, and by triggering cyclophilin-D (CypD)-dependent 318 
formation of the MPT pore via interaction of VDAC and mitochondrial adenine nucleotide 319 
translocator (ANT).  Both mechanisms are required for increased ROS formation and 320 
necrosis, and deficiency in RIPK3 resulted in enhanced survival of macrophages infected 321 
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with M. tuberculosis.  Interestingly, although MLKL-expression is increased in macrophages 322 
by M. tuberculosis infection, and MLKL-knockdown inhibited cell death in M. tuberculosis-323 
infected macrophages, evidence of MLKL phosphorylation was not directly provided by this 324 
study.  Our data complement and extend these findings.  We demonstrate RIPK3 and 325 
mitochondrial ROS-dependent cell death occurs in macrophages both in the presence and 326 
absence of TNFα, but that de facto phosphorylation of MLKL does not occur in this cell type 327 
in response to M. tuberculosis infection, either in vitro or in vivo in murine tuberculosis 328 
granulomas.  Furthermore, RIPK3-deficiency protected macrophages against M. 329 
tuberculosis-induced cell death.  However, we demonstrate that pMLKL-driven necroptosis 330 
does occur in fibroblasts in vitro in the presence of TNFα, and that pMLKL-driven 331 
necroptosis can be detected in vivo in murine TB lung granulomas, predominantly in non-332 
macrophages cell types resembling fibroblasts.   333 
 334 
M. tuberculosis infection of fibroblasts presents a particularly intriguing conundrum.  335 
Fibroblasts are recruited to TB granulomas where they are involved in tissue remodelling, 336 
and M. tuberculosis is able to replicate in fibroblasts in vitro 47, 48.  In situ PCR has 337 
demonstrated M. tuberculosis-infected fibroblasts in latently infected individuals, suggesting 338 
that fibroblasts and other non-professional APCs could contain a reservoir of bacteria 2.  339 
However, infected fibroblasts are not seen in active M. tuberculosis infection.  This has 340 
previously been attributed to the toxic effects of TNFα in active M. tuberculosis infection, 341 
where immune competent patients have high levels of circulating TNFα and pyresis.  47, 48.  342 
Our data demonstrate that the synergistic effects of M. tuberculosis infection and TNFα can 343 
cause necroptosis in fibroblasts, implicating necroptosis as the mechanism for enhanced 344 
toxicity of TNFα in M. tuberculosis-infected fibroblasts and potentially as the reason why M. 345 
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tuberculosis infected fibroblasts are not frequently observed in active tuberculosis.  346 
Furthermore, as proliferation of fibroblasts and a fibrotic response has been shown to be 347 
critical to the encapsulation of the granuloma and control of tuberculosis infection, this 348 
raises the possibility that the induction of necroptosis in fibroblasts by M. tuberculosis and 349 
TNFα may provide an escape route for the pathogen from the encapsulated granuloma and 350 
therefore aid bacterial dissemination and transmission 66.   351 
 352 
Our data support a strategy to pharmacologically target programmed necrosis in active M. 353 
tuberculosis lesions 25.  Active tuberculosis is characterised by necrotic lung damage, which 354 
is both detrimental to the host and aids release of viable bacteria and their transmission.  355 
Targeting programmed necrosis in macrophages or the necroptosis pathway in fibroblasts 356 
may protect these cells from the toxic effects of M. tuberculosis and TNFα, preventing 357 
necrotic tissue damage, inhibiting cavitation and augmenting participation in tissue 358 
remodelling.   359 
  360 
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Materials and Methods 361 
Bacterial culture 362 
M. tuberculosis GC1237 and H37Rv was grown at 37°C in Middlebrook 7H9 broth containing 363 
10% albumin/dextrose/catalase (ADC) plus 0.1% Tween-80 or on Middlebrook 7H11 364 
medium  containing 0.2% glycerol and 10% oleic acid/ADC (OADC) enrichment (Becton 365 
Dickinson).  For macrophage infections, bacteria were grown to late log phase (an OD600nm 366 
of 0.8-1.2) in 7H9 broth as described above, washed 1x in PBS-tween-80 0.05% and once in 367 
PBS before resuspension in RPMI 1640 complete medium.  OD600nm was used to estimate 368 
bacterial numbers, with OD600nm=1 = 1x10
8 cfu/ml.   369 
 370 
Macrophage and fibroblast cell culture 371 
J774A.1 murine macrophage-like cells, L929 murine fibroblasts,  THP-1 human monocytic 372 
cells and U937 human monocytic cells were cultured in RPMI 1640 complete medium 373 
containing 10% heat inactivated felt calf serum (FCS) and 5 mM L-glutamine. RAW264.7 374 
murine macrophage-like cells were grown in DMEM complete medium containing 10% FCS 375 
and 5 mM L-glutamine. J774A.1, L929 and RAW264.7 cells were seeded in 96-well plates 376 
and grown overnight at 37°C in 5% CO2 before mycobacterial infections and treatments to 377 
induce cell death.  THP-1 and U937 monocytes were differentiated to macrophages using 378 
25ng/ml PMA for 72 hours, then washed and rested for 24 hours before treatments to 379 
induce cell death.   380 
 381 
Human PBMCs were isolated from component donation blood cones (NHS Blood and 382 
Transplant Service) by density centrifugation using Ficoll-Histopaque.  The PBMC fraction 383 
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was harvested and monocytes isolated with CD14 MicroBeads (Miltenyi Biotec). Monocytes 384 
were differentiated to macrophages in complete RPMI supplemented with 1% sodium 385 
pyruvate and 1% penicillin/streptomycin in 24 or 96 well plates with 20ng/mL of 386 
macrophage colony-stimulating factor (M-CSF; Miltenyi Biotec). Fresh medium with 387 
cytokines was added at day 3 and macrophages were used for further experiments after 6 388 
days. 389 
 390 
Cell Survival Assays 391 
Cells in 96 well plates were treated with TNFα (0-25ng/ml; Miltentyi Biotec), zVAD-fmk (30 392 
µM, Promega), necrostatin (30 µM, Enzo) or Necrox-2 (30 µM Enzo) as indicated.  For 393 
mycobacterial infections, cells were infected with GC1237 for the times indicated in figure 394 
legends, and the bacteria removed by gently washing once with warm PBS-1%FCS before 395 
replacing with complete medium containing the treatments as indicated.  Plates were then 396 
washed 2x with PBS, fixed for 24 hours with 4% paraformaldehyde, washed with PBS and 397 
stained with crystal violet as previously described  19.   398 
 399 
Confocal microscopy for cell morphology  400 
J774A.1 cells were seeded in slide flasks, and the following day treated with TNF 25ng/ml, 401 
zVAD 30uM, Nec-1 30uM, 0.5mM H2O2, and 2.5ug/ml cyclohexamide.  After 20h, cells were 402 
washed twice with PBS and fixed with 4% paraformaldehyde.  Cells were washed and 403 
permeablised with 0.1% Triton-X100 for 3-5 minutes at room temperature, before staining 404 
with Alexa568-phalloidin (Molecular Probes) and DRAQ5 (Biostatus), mounting and viewing 405 
with a Zeiss LSM510META confocal microscope. 406 
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 407 
Western blot 408 
Following induction of cell death or mycobacterial infection, cells were lysed with RIPA 409 
buffer containing protease inhibitor cocktail, 2mM PMSF and 1mM sodium orthovanadate. 410 
M. tuberculosis-infected lysates were passed twice through 0.22µm spin filters (Corning 411 
Costar Spin X) before processing under biosafety level 1 conditions.   Protein concentration 412 
was measured using a BCA kit (Pierce) and 20 µg protein was subjected to reducing SDS-413 
PAGE on 10% Bis-Tris gels (Novex, Invitrogen) and transferred to a 0.2µm pore PVDF 414 
membrane.  Membranes were blocked with 10% BSA in tris-buffered saline (TBS) for 1 hour 415 
at room temperature, rinsed with  0.1% Tween-20 (TBST), and incubated overnight at 4°C 416 
with primary antibodies specific for MLKL phosphorylated at Ser345 (EPR9515(2))at a 417 
dilution of 1:2000, or anti beta III tubulin antibody (EPR9515(2), EP1331Y; Abcam) at a 418 
dilution of 1:10,000.  Blots were rinsed thrice with TBST for 10 minutes, and incubated with 419 
the secondary reagent goat anti-rabbit IgG-peroxidase at a dilution of 1:6000 for 90 minutes 420 
at room temperature.  Membranes were developed using Clarity ECL Western Blot 421 
Substrate (BioRad) and exposure to autoradiography film.   422 
 423 
RIPK3 shRNA knockdown cell lines 424 
J774A.1 macrophages were transduced with lentiviral particles expressing shRNA of RIP3K 425 
(sc-61483-V) or control shRNA particles (sc-108080) according to the manufacturer’s 426 
instructions (Santa Cruz).  Transduced cells were selected with 1.25µg/mL puromycin, and 427 
single cell colonies obtained by limiting dilution.  Macrophages were washed and plated 428 
without puromycin selection for 24 hours prior to their use in assays for necroptosis or 429 
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infection with M. tuberculosis.  Knockdown of RIP3K mRNA was confirmed by RT-PCR, using 430 
murine RIP-3 and beta-actin primers (sc-61483-PR and sc-29192-PR, Santa Cruz).   431 
 432 
Mouse infections and immunohistochemistry 433 
Animal experiments were performed in accordance with the Animals (Scientific Procedures) 434 
Act 1986.  Female Balb/c mice were infected intranasally with approximately 2x102 cfu of M 435 
.tuberculosis H37Rv (sample mean 2.13x102), and sacrificed 21 days post infection.  Excised 436 
lung tissue was fixed with 4% paraformaldehyde for 24 hours and embedded in paraffin 437 
wax.  4µm tissue sections were dewaxed, rehydrated, endogenous peroxidase activity 438 
blocked by incubation with 3% H2O2 in methanol and epitopes demasked with proteinase K. 439 
Samples were incubated with 1:50 pMLKL antibody in TBS; sequential sections were run 440 
with rabbit IgG as an isotype control.  Samples were incubated with biotinylated horse anti-441 
rabbit IgG and antibody binding was amplified using avidin-biotin-peroxidase conjugate.  442 
Samples were developed with NovaRed substrate (Vector Laboratories), and counter 443 
stained with Mayer’s haematoxylin.  Acid fast bacilli in lung sections were visualised using 444 
Ziehl-Neelsen staining.   445 
Statistical analysis 446 
One way ANOVA with Tukey’s post-hoc tests, and two way ANOVA with Sidak post hoc test 447 
were performed using GraphPad Prism v6 software.   448 
  449 
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 633 
Figure legends 634 
Figure 1.  Necroptosis of macrophage cell lines, human MDMs and murine fibroblasts 635 
treated with TNFα+zVAD.   636 
a) Human monocyte-derived macrophages (HMDMφ) were treated for 20 hours with 637 
50ng/mL TNF+DMSO, TNF+30µM zVAD and TNF+30µM zVAD + 30µM Nec-1, before 638 
measuring cell survival using a crystal violet assay (normalised to TNFα+DMSO treated 639 
control cells).  Results are mean +/- SEM n=4, and are representative of 3 independent 640 
experiments.  b) U937 macrophages were treated for 20 hours with 50ng/mL TNF, 641 
TNF+30µM zVAD and TNF+30µM zVAD + 30µM Nec-1, before measuring cell survival using a 642 
crystal violet assay (normalised to untreated control cells).  Results are mean +/- SEM n=10, 643 
and are representative of at least 2 independent experiments.  c) THP-1 were treated for 20 644 
hours with 50ng/mL TNF+DMSO, TNF+30µM zVAD, and TNF + 30µM zVAD + 30µM Nec-1, 645 
before measuring cell survival using a crystal violet assay (normalised to DMSO treated 646 
control cells).  Results are mean +/- SEM n=10.  d) L929 fibroblasts, e) J774A.1 macrophages 647 
and f) RAW macrophages were treated for 20 hours with 10ng/ml TNF+ DMSO, TNF + 30µM 648 
zVAD, and TNF + 30µM zVAD + 30µM Nec-1.  Results are mean +/- SEM n=10, are expressed 649 
as a percentage of DMSO treated controls, and representative of 2-3 independent 650 
experiments.  Statistics are one way ANOVA with Tukey’s post-test.   ****p<0.0001.  g) 651 
Western blot of lysates of L929 and J774A.1 macrophages that had been treated with 652 
10ng/ml TNFα and 25ng/ml TNFα respectively in the presence of 30µM zVAD.fmk for 18 653 
hours, developed with antibodies against MLKL phosphorylated at Ser345, or βIII tubulin as 654 
a loading control.  Results are representative of 2-3 independent experiments.  h) J774A.1 655 
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macrophages were seeded on glass slide flasks and untreated or treated with 656 
cyclohexamide 2.5µg/ml, 0.5mM H2O2,  TNFα 25ng/ml, TNF + 30µM zVAD, and TNF + 30µM 657 
zVAD + 30µM Nec-1.  After 20 hours, cells were stained with Alexa-568-phalloidin (displayed 658 
as red) and counterstained with DRAQ5 (displayed as blue) before viewing by confocal 659 
microscopy.  Results are representative of 2 independent experiments. 660 
Figure 2. M. tuberculosis induces RIPK1-dependent cell death in the presence of excess 661 
TNFα in fibroblasts and macrophages, but only induces MLKL phosphorylation in 662 
fibroblasts.  A) L929 murine fibroblasts were infected with M. tuberculosis for 24 hours, 663 
then treated with DMSO or 30µM Nec-1 in the presence or absence of 10ng/ml TNFα for 18 664 
hours, before measuring cell survival using a crystal violet assay.   Results are mean +/- SEM 665 
of n=6 samples, and are expressed as a percentage of the uninfected control of each 666 
treatment.  Statistics are two way ANOVA with Sidak post-test.  Ns not significant; **p<0.01; 667 
****p<0.0001.  B) Western blot of L929 fibroblasts infected with MOI 20 M. tuberculosis for 668 
24 hours, then treated with TNFα for 24 hours, or with TNFα + 3µM zVAD for 18 hours, 669 
developed with anti-pMLKL antibody and anti beta-III tubulin antibody.  C)  J774A.1 murine 670 
macrophages were infected with M. tuberculosis for 3 hours, then treated with DMSO or 671 
30µM Nec-1 in the presence or absence of 25ng/ml TNFα for 48 hours.  Results are mean +/- 672 
SEM of n=10 samples, and are expressed as a percentage of the uninfected control of each 673 
treatment.  Statistics are two way ANOVA with Sidak post-test.  Ns not significant; 674 
****p<0.0001.  D) Western blot of J774A.1 cells infected with MOI 10 M. tuberculosis for 3 675 
hours and subsequently treated with 25ng/ml TNFα for 24 hours, or with TNF + 30µM zVAD 676 
for 18 hours, developed with anti-pMLKL antibody and anti beta-III tubulin antibody.  A-D) 677 
All results are representative of at least 2 similar experiments.   678 
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 679 
Figure 3.  RIPK3 and mitochondrial ROS mediate M. tuberculosis-induced cell death both 680 
in the presence and absence of TNFα.   a) WT J774A.1 macrophages, RIP3K shRNA 681 
knockdown J774A.1 macrophages, and control shRNA J774A.1 macrophages were treated 682 
for 20 hours with DMSO control or 30µM zVAD.fmk in the presence of 25ng/mL TNF, before 683 
measuring cell survival using a crystal violet assay.  Results are mean +/- SEM of n=10 684 
samples and are expressed as a percentage of the TNFα+DMSO-treated control for each 685 
condition.   Statistics are two way ANOVA with Sidak post-test.  **p<0.01; ****p<0.0001.  686 
Results are representative of 3 independent experiments. b) Knockdown of RIP3K mRNA 687 
was confirmed by RT-PCR, using murine RIP-3 and beta-actin primers (sc-61483-PR and sc-688 
29192-PR, Santa Cruz).  c) RIP3K hRNA knockdown J774A.1 macrophages, and control shRNA 689 
J774A.1 macrophages were infected with M. tuberculosis for 3 hours, and subsequently 690 
incubated in the absence or presence of 25ng/ml TNF for 48 hours, before measuring cell 691 
survival using a crystal violet assay.  Results are mean +/- SEM of n=10 samples, and are 692 
expressed as a percentage of the uninfected control of each treatment. Statistics are two 693 
way ANOVA with Sidak post-test. *p>0.05; ***p<0.001; ****p<0.0001.  Results are 694 
representative of 2 independent experiments d) J774A.1 macrophages were infected with 695 
M. tuberculosis for 3 hours and incubated with Necrox-2 in the presence and absence of 696 
TNFα for 24 hours, before measuring cell survival using a crystal violet assay.  Results are 697 
mean +/- SEM of n=10 samples, and are expressed as a percentage of the uninfected control 698 
of each treatment. Statistics are one way ANOVA with Tukey’s post-test. *p>0.05; 699 
***p<0.001; ****p<0.0001.   700 
 701 
33 
 
Figure 4.  Murine tuberculosis granulomas contain non-macrophage cells undergoing 702 
pMLKL driven necroptosis. Mice were infected with M. tuberculosis by intranasal challenge 703 
and lung pathology analysed at 21d.p.i.  A) H&E stain. Granulomatous inflammation within 704 
the lung with abundant foamy macrophages and small areas of necrosis (asterisk).  Original 705 
magnification: 100X. Inset shows Ziehl-Neelsen staining revealing numerous acid fast bodies 706 
(AFBs) present within the lesion. Original magnification: 400X.  B) Non-immune 1 ͦ antibody 707 
isotype control staining for immunohistochemistry. Original magnification: 400X.  C)  pMLKL 708 
immunohistochemistry. Positive staining within the cytoplasm of elongated cells within the 709 
granulomatous inflammation and necrosis.  Original magnification: 400X. C) pMLKL 710 
immunohistochemistry. Positive staining is observed predominantly in cells with fusiform-711 
nuclei (black arrow) adjacent to non-immunoreactive foamy macrophages (white arrow) 712 
and necrotic cell debris. Original magnification: 400X.   713 
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